| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $19.7M | — | -12.8% |
| SG&A Expense | $8.9M | — | +2.3% |
| Operating Income | -$34.2M | — | +92.8% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$9.9M | — | +91.7% |
| EPS (Basic) | -$0.12 | — | +92.3% |
| EPS (Diluted) | -$0.12 | — | +92.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $133.1M | -33.2% | -55.6% |
| Current Assets | $311.1M | -9.5% | -37.5% |
| Total Assets | $542.8M | -9.5% | -70.5% |
| Current Liabilities | $13.1M | -72.5% | -38.9% |
| Total Liabilities | $24.9M | -61.3% | -38.2% |
| Stockholders' Equity | $205.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$51.1M | — | -150.8% |
| Capital Expenditures | $8.2M | — | -8.2% |
| Investing Cash Flow | -$16.3M | — | -86.4% |
| Financing Cash Flow | -$73K | — | -46.0% |
| Free Cash Flow | -$59.3M | — | -102.4% |
| -67.8% |